Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression-Reference-Cited by-同舟云学术

Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expression

Published:2005-07 Issue:4 Volume:23 Page:261-267
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Heresi Gustavo A.,Wang Jingcheng,Taichman Russell,Chirinos Julio A.,Regalado Jacinto J.,Lichtstein Daniel M.,Rosenblatt Joseph D.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference39 articles.

1. Prostate cancer;Garnick;Ann Intern Med,1993

2. Presentation of prostatic adenocarcinoma, with cervical LAD;Chitale;Otolaryngol Head Neck Surg,2001

3. Metastatic prostatic carcinoma to supradiaphragmatic lymph nodes;Cho;Am J Surg Pathol,1987

4. Carcinoma of the prostate with soft tissue or non-regional lymphatic metastases at the time of diagnosis;Saeter;Br J Urol,1984

5. Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase;Yam;Cancer,1983

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis;Seminars in Cancer Biology;2022-11

2. C-C Chemokine Receptor 7 in Cancer;Cells;2022-02-14

3. Identification and verification of immune-related gene prognostic signature based on ssGSEA for breast cancer;Central European Journal of Immunology;2022

4. Left axillary lymphadenopathy as initial presentation of metastatic prostate cancer: A rare case report;International Journal of Surgery Case Reports;2021-05

5. CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change;Frontiers in Molecular Biosciences;2021-04-01